Abstract: An optical subscriber line terminal unit and a state transition control method are provided which are capable of stabilizing operation. State information storing means, which is a nonvolatile memory, stores state information about the unit. Startup preparatory state shifting means causes a shift to a startup preparatory state at startup. Flag setting means sets an emergency stop state flag during the period of the startup preparatory state if it is judged based on the state information that a state before the startup is an emergency stop state. State transition control means causes a shift from the startup preparatory state to the emergency stop state if the emergency stop state flag is set, and causes a shift from the startup preparatory state to an initial state if the emergency stop state flag is not set.

Abstract: A delay adjustment unit and optical network unit which efficiently adjust the delay time of upstream data to improve the quality of data transmission services. Upstream transmission data is segmented into small data blocks. A downstream receiver receives control information on which upstream data blocks are granted or not granted to the unit. It also received an equalization delay update request that commands the unit to update its current equalization delay parameter. When this equalization delay update request is received, a delay adjustment controller controls the delay of each data block, depending on whether the transmission of each subsequent data block is granted. An upstream transmitter then transmits the granted data blocks with the adjusted delay times.

Abstract: A mounting structure for a tubular member is disclosed. At least a claw (11) making up a protrusion is formed on the outer surface of a drain hose (1) making up a tubular member. At least an annular depressed portion (22) is formed on the inner surface of a holding hole (21) of a grommet (2) making up a holding member. The claw (11) and the depressed portion (22) are fitted with each other, so that the drain hose (1) is securely held in a manner such that it cannot come off from the grommet (2) supported by a body panel (3). The outer surface of the drain hose (1) is formed with a mark (12) providing an indication of the amount of insertion.

Abstract: There is provided an NC machine tool with tiltable spindle unit capable of being used both as vertical and inclined spindle type machine tools without restrictions on stroke and capable of easily carrying out tool measurement, alignment of a work piece with a tool, and truing. The NC machine tool includes: a spindle unit having a spindle serving both as a vertical spindle and an inclined spindle; and a tilting mechanism having a turning shaft for pivotably supporting the spindle unit on a vertical plane. The turning shaft has a center line of rotation which is arranged in the vicinity of a top end of a tool on a center line of the tool.

Abstract: Disclosed is a monitoring device for a machine tool, which monitors operations in work machining to increase the precision level of the yield of the work. To monitor a load current supplied to a machining motor in 1-cycle units which run from the start of the machining to the end of the machining, sampling points are taken at shorter intervals along the time axis of the machining in areas where the machining is complex, and in areas where the machining is simple sampling points are taken at longer intervals along the time axis of the machining; and at each sampling point the sampling data are stored and undergo numerical processing. Then, the actually measured value of the load current is compared to determine whether or not the actually measured value is within a range of an upper and a lower limit which are determined by a standard deviation value calculated from the sampling data at each sampling point, to thereby monitor the machining process.

Abstract: An image display processing apparatus, includes an issuance unit for issuing a display content of one frame including images of a plurality of objects to be displayed on a screen, a monitoring unit for detecting a display content having a data amount in excess of a predetermined value, a selection unit for selecting at least one of the plurality of objects included in the display content, and an image processing unit for processing an image for the display content excluding the image of the object selected by the selection unit and displaying the processed image on the screen.

Abstract: A fixed-length cell multiplexing/distributing processing is disclosed. The apparatus for this processing includes a plurality of fixed-length cell transmitting apparatuses, each of which sends a fixed-length cell, and a fixed-length cell multiplexing apparatus which multiplexes the fixed-length cells received from the fixed-length cell transmitting apparatuses and outputs the thus multiplexed cells. One of the plurality of fixed-length cell transmitting apparatuses is configured as a highest-priority fixed-length cell transmitting apparatus. Further, the highest-priority fixed-length cell transmitting apparatus comprises a fixed-length cell storage section and a fixed-length cell read control section. The fixed-length cell multiplexing apparatus comprises a plurality of FIFO storage sections, an FIFO control section, and a multiplexing section. With this structure, information to be notified is divided into fixed-length cells for transmission.

Abstract: A data communication method enables communications between terminals adapted to handle frame structure data having different formats. The terminals are connected via an asynchronous transfer mode (ATM) network in which frame structure data is transmitted in a form of an ATM cell. The terminals include at least a first terminal and a second terminal. The first terminal is adapted to handle data having a super frame (SF) format. The second terminal is adapted to handle data having an extended super frame (ESF) format. A type of frame format of frame structure data to be sent to one of the terminals is distinguished by detecting a synchronization pattern of the frame structure data. The frame structure data is converted when the frame structure data is sent to the one of the terminals so that the converted frame structure data has a type of frame format corresponding to the detected synchronization pattern.

Abstract: A structure of a capacitor includes a first metal interconnection layer, a dielectric film, and a second metal interconnection layer. The dielectric film is formed on the first metal interconnection layer. The second metal interconnection layer is formed on the dielectric film. The dielectric film is a dielectric film formed by bias-ECR plasma CVD.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitogen or oxygen atom,--CH.sub.2 OH.sub.3 group or ##STR3## group, in which R.sub.3 and R.sub.

Abstract: A size checking apparatus is employed to check sizes or dimensions of a work.

Abstract: A process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives of the formula ##STR1## wherein X and Y are hydrogen atom, halogen atom or alkyl group, and R.sub.1 is hydrogen atom or alkyl group,intermediates thereof, as well as a process for the preparation of the intermediates.

Abstract: The invention relates to a hydantoin derivative, salt thereof, process for the preparation thereof, and medicine containing the derivative. The derivative is represented by the formula ##STR1## wherein M is --CONH--NHR.sup.1 group, --CONH--OR.sup.2 group, ##STR2## in which R.sup.1 is hydrogen atom, an alkyl group, an alkenyl group, a phenyl radical, a substituted phenyl group, a naphthyl radical, a substituted naphthyl group, a pyridyl radical, a furyl radical or a thienyl radical, R.sup.2 is a hydrogen atom, an alkyl group, a phenyl radical or a substituted phenyl group, R.sup.3 and R.sup.4 are the same or different independently, each being a phenyl radical, or an aralkyl group, or R.sup.3 may form a substituted or non-substituted C.sub.5-6 saturated heterocyclic ring together with R.sup.4 and a possible nitrogen or oxygen atom, R.sup.5 forms a substituted or non-substituted saturated heterocyclic ring together with R.sup.6 and a possible nitrogen or oxygen atom, R.sup.

Abstract: Hydantoin derivatives of the formula ##STR1## wherein Ra and Rb are same or different, each being hydrogen atom, alkanoyl, substituted or none-substituted aroyl, heteroaroyl, alkoxycarbonyl, substituted or none-substituted aralkoxycarbonyl, aryloxycarbonyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl, substituted or none-substituted N-aralkylcarbamoyl, alkoxyalkyl, 1-(acyloxy)-alkyl, alkylmercapto, substituted or none-substituted arylmercapto, alkylsulfinyl, substituted or none-substituted arylsulfinyl, alkylsulfonyl or substituted or none-substituted arylsulfonyl, but both of Ra and Rb do not concurrently mean hydrogen atom,a process for the preparation of the derivatives, and use thereof as an agent for preventing and curing chronic complications due to diabetes.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivatives, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## group, in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitrogen or oxygen atom, --CH.sub.2 OR.sub.3 group or ##STR3## group, in which R.sub.3 and R.sub.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group, in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitrogen or oxygen atom, ##STR3## in which R.sub.3 and R.sub.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group, in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitogen or oxygen atom, ##STR3## in which R.sub.3 and R.sub.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## group, in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitrogen or oxygen atom, --CH.sub.2 OR.sub.3 group or ##STR3## group, in which R.sub.3 and R.sub.

Abstract: A multi-layered element for the quantative analysis of an immuno-reactant having a water-impermeable and light-transmissible support layer; a coloring reagent layer carried by said support layer and containing a hydrophilic polymer as a binder; and a reaction layer covering said reagent layer and made of a porous matrix. When the analyte immunoreactant is an antigen, said reaction layer contains the specific antibody for the antigen, the antibody being immobilized by a first water-insoluble carrier. When the analyte immuno-reactant is an antibody, said reaction layer contains the specific antigen for the antibody. The reaction layer contains an enzyme substrate immobilized by a second water-insoluble carrier different from said first water-insoluble carrier.

Abstract: Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,in which R is hydrogen atom, an alkyl group, --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n is an integer of 1 to 113) or substituted phenyl, ##STR2## in which R.sub.1 and R.sub.2 are same or different independently, each is hydrogen atom, an alkyl group, substituted phenyl or --(CH.sub.2 CH.sub.2 O)nCH.sub.3 group (n has the meaning as referred to) or R.sub.1 may form a heterocyclic ring together with R.sub.2 and nitrogen or oxygen atom, ##STR3## in which R.sub.2 and R.sub.